Generic Biologics Bill Could Be Follow Up To Medicare Rx Benefit - Haddad
Executive Summary
Legislation permitting generic versions of biological products will be a natural outgrowth of the addition of prescription drug coverage to Medicare, Hadco Biotechnology CEO William Haddad predicted during a Food & Drug Law Institute conference Dec. 11 in Washington, D.C.